Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas: Clinical Outcomes, Prognostic Factors, and the Role of Adjuvant Therapy | Citedby Results | Visceral Medicine | Karger Publishers

Skip to Main Content

Skip Nav Destination

Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas: Clinical Outcomes, Prognostic Factors, and the Role of Adjuvant Therapy

Viszeralmedizin (2015) 31 (1): 43–46.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Comparison of patients with invasive intraductal papillary mucinous carcinoma and invasive ductal carcinoma of the pancreas: a pathological type- and stage-matched analysis

Wataru Izumo
Ryota Higuchi
Toru Furukawa
Takehisa Yazawa
Shuichiro Uemura
Yutaro Matsunaga
Masahiro Shiihara
Masakazu Yamamoto

Scandinavian Journal of Gastroenterology (2019) 54 (11): 1412.

Intraductal Papillary Mucinous Neoplasm of the Pancreas

Zhi Ven Fong
Carlos Fernández-del Castillo

Surgical Clinics of North America (2016) 96 (6): 1431.